Lovastatin and Librium drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lovastatin (lovastatin) and Librium (chlordiazepoxide hydrochloride). Common drug interactions include blister among females and application site erythema among males.
The phase IV clinical study analyzes what interactions people have when they take Lovastatin and Librium. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.
What is Lovastatin?
Lovastatin has active ingredients of lovastatin. It is often used in high blood cholesterol. eHealthMe is studying from 33,048 Lovastatin users. Check the latest studies of Lovastatin.
What is Librium?
Librium has active ingredients of chlordiazepoxide hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 2,490 Librium users. Check the latest studies of Librium.
15 people who take Lovastatin and Librium together, and have interactions are studied.

What are the common drug interactions of Lovastatin and Librium, by gender? *:
female:
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
- Blue toe syndrome (blue toe syndrome is a lack of blood flow to the toes causing a blue discoloration)
- Cellulitis (infection under the skin)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Depression
- Dry eye (lack of adequate tears)
- Dysarthria (speech disorder)
- Electrolyte imbalance
- Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
male:
- Application site erythema (redness of the skin at application site)
- Application site irritation
- Arteriosclerosis (thickening and hardening of arteries)
- Balance disorder
- Blood creatine phosphokinase increased
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Chest pain
- Confusion
- Contusion (a type of hematoma of tissue in which capillaries)
- Fall
What are the common drug interactions of Lovastatin and Librium, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
- Type 2 diabetes mellitus
30-39:
n/a
40-49:
- Abnormal behaviour
- Blood creatine phosphokinase increased
- Chest pain
- Confusion
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Injury
- Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
- Pain
- Speech disorder
50-59:
- Chest pain
- Hypoaesthesia (reduced sense of touch or sensation)
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Muscular weakness (muscle weakness)
- Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
60+:
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Limb injury
- Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
- Fear
- Gait disturbance
- Hallucination (an experience involving the perception of something not present)
- Localised infection (infection at the single location)
- Loss of consciousness
- Panic attack
- Poor peripheral circulation
What are the existing conditions these people have? *
- Depression: 4 people, 26.67%
- Quit Smoking: 3 people, 20.00%
- Pain: 3 people, 20.00%
- Panic Disorder: 2 people, 13.33%
- Tardive Dyskinesia (a disorder that involves involuntary movements): 1 person, 6.67%
- Agitation (state of anxiety or nervous excitement): 1 person, 6.67%
- Alcohol Withdrawal Syndrome: 1 person, 6.67%
- Arterial Occlusive Disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked): 1 person, 6.67%
- Asthma: 1 person, 6.67%
- Back Pain: 1 person, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Lovastatin and Librium?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Lovastatin (33,048 reports)
- Librium (2,490 reports)
Browse all drug interactions of Lovastatin and Librium:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lovastatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Librium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lovastatin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Librium and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on lovastatin and chlordiazepoxide hydrochloride (the active ingredients of Lovastatin and Librium, respectively), and Lovastatin and Librium (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Duoneb and Januvia - now
- Heart Rate Irregular and Hot Flush - 4 seconds ago
- Drug interactions of Dupixent and Armodafinil - 4 seconds ago
- Could Septra Ds cause Nosebleed? - 8 seconds ago
- Gait Disturbance and Knee Joint Replacement - 13 seconds ago
- Glaucoma and Stress And Anxiety - 20 seconds ago
- Could Singulair cause Papilloedema? - 21 seconds ago
- Could Singulair cause Blindness? - 25 seconds ago
- Could Singulair cause Eosinophilic Pneumonia? - 27 seconds ago
- Could Singulair cause Hypopituitarism? - 28 seconds ago